Hirokazu Ogino

5PUBLICATIONS
23CO-AUTHORS
Predictive and prognostic markersCellular nervous systemMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 26, 2026
Tumor Necrosis on Routine Pretreatment CT as a Potential Prognostic Marker in Advanced NSCLC Treated With Immune Checkpoint Inhibitor Monotherapy: A Two-Center Retrospective Study.

|May 22, 2025
Glioma-neuronal circuit remodeling induces regional immunosuppression.

Takahide Nejo, Saritha Krishna, Akane Yamamichi

|Feb 19, 2025
Tumour-wide RNA splicing aberrations generate actionable public neoantigens.

Darwin W Kwok, Nicholas O Stevers, Iñaki Etxeberria

|Jul 15, 2024
Granulocyte colony-stimulating factor has the potential to attenuate the therapeutic efficacy of chemo-immunotherapy for extensive-stage small-cell lung cancer.

Yuki Tsukazaki, Hirokazu Ogino, Yoshio Okano

|Jan 28, 2021
Blockade of PD-1/PD-L1 Pathway Enhances the Antigen-Presenting Capacity of Fibrocytes.

Tania Afroj, Atsushi Mitsuhashi, Hirokazu Ogino

Pageof 1

Frequent Collaborators

2 joint publications

Atsuro Saijo

2 joint publications

Takahide Nejo

2 joint publications

Hideho Okada

1 joint publications

Tania Afroj